Recent News
Appellation: Appili (APLI.V), and its Stealth Appeal in the Chaos that is COVID-19
Major Armand Balboni, MD, PhD, JD CEO, Appili Therapeutics, Nova Scotia, Canada Media outlet that we are, the inevitability of COVID-19’s tumult was about as …
The BioPub Certainty Principle: Getting All Quant with Cleveland
Werner Heisenberg, the father of quantum physics. So much uncertainty…….. Editor’s foreword: Longtime BioPub contributing editor Cleveland ( a nom de plume) is our most …
The Scoop on Investing in Phileas
Philippe Calais, PharmD, PhD, CEO of start-up antisense therapeutics firm Phileas Pharmaceuticals In a 4 April 2020 webcast (see webcast section of this website), BioPub editors introduced …
May Oui: Open Table May 2020
No, it would be too facile for me to lead you to an open table this month with pictures of lilacs and some or another …
Rubbing Elbows with New CohBar CEO Steven Engle (A Live Webcast, Friday, 1 May 2020, at 12 noon Eastern)
CohBar CEO Steven B. Engle….in his debut appearance at BioPub We revere the company and practically genuflect at the mention of its name. You know, THAT …
Algernon’s Ifenprodil Enters the Covid-19 Fray: A Live Discussion with Algernon CEO Moreau and CSO Williams
Algernon Chief Scientific Officer Mark Williams, PhD The pace of activity at Algernon ($AGNPF) is breakneck, and we suspect readers can barely keep up with the flurry …
Apace with Acurx: A Live Discussion with Founder-Partners David Luci, JD, and Bob DeLuccia (Friday, 24 April, noon EST)
David Luci, JD, and Bob DeLuccia, founders and leaders of Acurx, the best antibiotics investment we know Updating BioPub readers and Torrey Hills Capital clients …
For All Phileas Investors: Phileas Term Sheet and Private Placement Memorandum
Philippe Calais, Pharm.D., Ph.D., CEO and founder of new private biotech Phileas Pharmaceuticals, now seeking seed funding Please send a “dummy” or one-word message to …
Capricor: Is the GOAT about to Morph into a Raging Bull? A Conversation with CEO Linda Marban and CFO AJ Bergmann
Capricor CEO Linda Marban, PhD Except for a legacy position in Merck, Capricor ($CAPR) now stands as the oldest position in my biotech portfolio. Despite a certain history …
The Camel Question……….
From one of many websites discussing this topic, think of the mitochondrial machinery as a series of whirring Dreml tools: “Deuterium will enter the body …
Guest columnist: Tony Pullen Sticks His Neck Out about Algernon
In my career there have been times when an investment idea reaches a point of obviousness that it must be shared. My reason for reaching …
Important Update Webcast with Algernon CEO Moreau and CSO Williams
Special webcast with Algernon Pharmaceuticals to discuss the spate of recent news items regarding company initiatives, as covered in press releases already published here. CEO …
Join The BioPub
Community
Register now and gain access to our medical and science forums.
Join The BioPub
Community
Register now and gain access to our medical and science forums.
BIOPUB Webcasts
BioPub is the only biotech investing forum regularly providing readers top-tier unfettered live access to biotech executives…in the form of live webcasts once or twice weekly with new companies that have evoked editorial attention and established companies in the BioPub stable of investments. Our copyrighted, exclusive webcasts are recorded and archived on this website and sometimes on our youtube channel. Have a question for which the answer will influence your investment decision? Show up and ask.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
BIOPUB Webcasts
BioPub is the only biotech investing forum regularly providing readers top-tier unfettered live access to biotech executives…in the form of live webcasts once or twice weekly with new companies that have evoked editorial attention and established companies in the BioPub stable of investments. Our copyrighted, exclusive webcasts are recorded and archived on this website and sometimes on our youtube channel. Have a question for which the answer will influence your investment decision? Show up and ask.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
BioPub
a publication of Helixir Media, LLC
- KSS, MD, PhD, (New York): Founder
- Alan Harris (London): Founder
- KSS, MD, PhD, FACP: Editor-in-Chief and Publisher
- Jonathan Coulborn, MBA: Editor
- YVR Trader: Managing Editor
- Glenn Newberry: Editor-at-Large
- Cleveland: Contributing Editor
- cw99, MD: Associate Editor
- Paul Harte: Associate Editor
- OneMdcn: Associate Editor
EDITORIAL BOARD
- Jonathan Coulborn: MBA, Chairman
-
- Tom Nall: Tampa, Florida
- cw99, MD: Austin, TX
- KSS, MD, PhD: ex officio
- Paul Harte: San Francisco, CA
- YVR Trader: Vancouver, BC
- Melanie, MS: New York, NY
-
Original BioPub Photographic Artwork
by Michael Wideman (Tulsa, OK)
and KSS, Copyright 2017 -
"Hector the BioBull" Design by
Bryce Choquer (Vancouver, BC)
and KSS, Copyright 2020
“The individual has always had to struggle to keep from being overwhelmed by the tribe. To be your own man is a hard business. If you try it, you’ll be lonely often, and sometimes frightened. But no price is too high to pay for the privilege of owning yourself.”
“Do the things you really want to do if you possibly can. Don’t wait for circumstances to be exactly right. You’ll find that they never are.”
- Rudyard Kipling (often misattributed to Friedrich Nietzsche)
BioPub
a publication of Helixir Media, LLC
- KSS, MD, PhD, (New York): Founder
- Alan Harris (London): Founder
- KSS, MD, PhD, FACP: Editor-in-Chief and Publisher
- Jonathan Coulborn, MBA: Editor
- YVR Trader: Managing Editor
- Tony Pullen: Editor-at-Large
- Glenn Newberry: Editor-at-Large
- Cleveland: Contributing Editor
- cw99, MD: Associate Editor
- Paul Harte: Associate Editor
- OneMdcn: Associate Editor
EDITORIAL BOARD
- Jonathan Coulborn: MBA, Chairman
-
- Tom Nall: Tampa, Florida
- cw99, MD: Austin, TX
- KSS, MD, PhD: ex officio
- Paul Harte: San Francisco, CA
- YVR Trader: Vancouver, BC
- Melanie, MS: New York, NY
-
Original BioPub Photographic Artwork
by Michael Wideman (Tulsa, OK)
and KSS, Copyright 2017 -
"Hector the BioBull" Design by
Bryce Choquer (Vancouver, BC)
and KSS, Copyright 2020
Company Contact
- leon@biopub.co
- 4711 Hope Valley Road, Suite 4F, Durham, NC 27707
